numer
human
studi
anim
model
implic
variou
infecti
agent
pathogenesi
vascul
suscept
host
howev
link
infect
vascul
complex
incomplet
understood
fact
differ
agent
induc
type
vascul
case
leukocytoclast
vascul
exemplifi
convers
agent
give
rise
panopli
host
respons
rang
clinic
silent
infect
local
organ
involv
devast
widespread
vascul
tradit
vasculitid
classifi
primari
secondari
depend
whether
incit
agent
often
invari
infect
origin
identifi
howev
develop
increasingli
refin
diagnost
tool
led
reclassif
vasculitid
previous
consid
idiopath
infect
relat
instanc
cryoglobulinem
vascul
known
relat
hepat
c
viru
hcv
infect
major
case
addit
circumstanti
evid
suggest
even
vasculitid
still
classifi
primari
might
caus
trigger
least
case
environment
agent
mani
question
howev
remain
debat
exampl
mechan
induc
maintain
vascul
factor
account
differ
suscept
develop
vascul
differ
individu
factor
modul
diseas
sever
specif
vascular
bed
organ
involv
differ
vasculitid
role
infect
agent
primari
vascul
andlast
least
therapeut
implic
recognit
infect
etiolog
vascul
main
aim
review
elucid
mechan
infecti
agent
could
induc
vascul
provid
updat
human
vasculitid
proven
suspect
infecti
origin
implic
treatment
also
briefli
discuss
theoret
pathogen
induc
vascul
number
differ
mechan
direct
endotheli
invas
damag
probabl
main
mechan
oper
rickettsi
infect
howev
major
case
vascul
mainli
result
immun
respons
trigger
offend
agent
humor
immun
respons
immun
complex
format
deposit
around
vessel
wall
thought
primari
mechan
leukocytoclast
vascul
molecular
mimicri
might
lead
autoantibodi
product
also
activ
autoreact
lymphocyt
cellmedi
immun
respons
without
granulomata
format
recogn
featur
largevessel
vasculitid
although
link
infecti
agent
remain
debat
less
common
mechan
postul
underpin
vascul
infectiontrigg
immun
dysregul
antiidiotyp
respons
experiment
model
provid
evid
variou
infecti
agent
induc
vascul
suscept
anim
model
offer
valuabl
insight
pathogen
mechan
oper
vascul
although
none
develop
far
close
reproduc
stigmata
human
vascul
possibl
except
leukocytoclast
vascul
chlamydia
pneumonia
cp
obligatori
intracellular
gramneg
bacterium
shown
induc
alter
aortic
wall
particular
fong
et
al
demonstr
intratrach
infect
cp
new
zealand
white
rabbit
fed
standard
diet
abl
induc
atherosclerot
chang
one
anim
associ
adventiti
lymphocyt
infiltr
latter
find
suggest
role
cp
induc
adventiti
periarter
human
cp
infect
link
gca
giant
cell
arter
minor
case
character
histolog
adventiti
periarter
absenc
typic
transmur
infiltr
howev
relationship
cp
infect
gca
remain
matter
debat
see
addit
bacteria
number
virus
demonstr
abl
trigger
vascul
porcin
reproduct
respiratori
syndrom
viru
prrsv
well
host
herpesvirus
includ
particular
betaherpesviru
cytomegaloviru
cmv
swine
prrsv
shown
caus
system
smallvessel
vascul
skin
purpura
renal
lesion
similar
observ
human
leukocytoclast
vascul
pathogenesi
vascul
like
due
immun
complex
immunofluoresc
demonstr
presenc
immunoglobulin
complement
around
affect
vessel
wall
macrophag
endotheli
cell
found
host
viral
antigen
earli
onset
follow
infect
well
low
morbid
mortal
observ
keep
benign
cours
leukocytoclast
vascul
human
murin
cmv
infect
one
wide
use
model
vascul
gain
better
understand
pathogenesi
cmvinduc
diseas
persoon
et
al
develop
two
model
cmv
infect
first
model
local
cmv
infect
result
develop
paw
thicken
erythema
follow
purpura
batch
anim
inject
highdos
cmv
develop
sever
lesion
progress
overt
skin
ulcer
clinic
manifest
resolv
within
week
wherea
anim
treat
highdos
cmv
kill
day
infect
ethic
reason
initi
histolog
show
sign
endotheli
activ
associ
perivascular
cmvposit
mononuclear
cell
infiltr
later
chang
includ
colon
endotheli
cell
cmv
frank
vascul
thrombot
occlus
second
model
gener
cmv
infect
induc
intraperiton
administr
viru
result
multipl
organ
patholog
includ
hemorrhag
inflamm
gastrointestin
ulcer
cmvencod
antigen
found
especi
mononuclear
inflammatori
cell
organ
peripher
blood
model
provid
import
clue
mechan
underpin
cmvinduc
vascul
first
local
gener
infect
result
vascular
chang
capillari
small
venul
mainli
affect
second
mononuclear
cell
appear
becom
infect
viru
endotheli
cell
suggest
role
mononuclear
cell
transport
viru
thu
spread
infect
third
higher
viral
load
associ
sever
diseas
latter
find
might
relev
human
diseas
cmv
infect
mostli
describ
immunodefici
patient
unabl
mount
effect
respons
thu
erad
cmv
addit
peripher
vessel
vascul
cmv
also
shown
abl
caus
aortiti
presti
et
al
infect
wildtyp
mice
mice
lack
interferongamma
receptor
ifngr
intraperiton
murin
cmv
strain
develop
aortic
adventiti
lesser
extent
intima
inflamm
character
mononuclear
cell
infiltr
arter
associ
cmv
antigen
aortic
media
howev
wherea
wildtyp
anim
lesion
resolv
day
postinfect
ifngr
mice
signific
arter
late
day
postinfect
main
point
studi
first
cmv
caus
aortiti
second
ifng
crucial
curb
vascular
inflamm
import
ifng
regul
respons
cmv
born
invitro
explant
reactiv
model
author
demonstr
ifng
could
revers
inhibit
cmv
reactiv
latenc
case
point
ifng
also
shown
control
vascular
inflamm
model
gamma
largevessel
vascul
anoth
cytokin
shown
downregul
develop
gamma
vascul
receptor
antagonist
anoth
herpesviru
use
induc
vascul
anim
herp
simplex
viru
hsv
studi
involv
icr
strain
mice
earlob
mice
inocul
hsv
type
solut
thirti
mice
inocul
cultur
medium
serv
control
four
week
later
second
inocul
perform
mice
inocul
hsv
manifest
chang
earli
day
first
inocul
common
sign
facial
hair
loss
erythema
skin
ulcer
scratch
earlob
eye
diseas
includ
uveiti
mice
rel
sever
manifest
also
mice
without
overt
clinic
sign
show
poor
gener
condit
die
second
inocul
arthriti
oral
genit
ulcer
kerat
main
featur
manifest
gener
sever
appear
initi
inocul
vascul
demonstr
intestin
oral
ear
lobe
genit
epitheli
lesion
hsv
dna
sequenc
detect
polymeras
chain
reaction
lesion
skin
gastrointestin
tract
affect
mice
normal
healthi
skin
find
particularli
appear
second
inocul
similar
seen
human
diseas
abd
typic
character
oral
genit
ulcer
often
associ
inflammatori
eye
diseas
arthriti
howev
model
infect
mice
develop
abdlik
manifest
defin
least
two
sign
around
die
infect
remain
healthi
develop
singl
sign
diseas
specul
develop
vascul
repres
immun
reaction
attempt
clear
viru
mice
unabl
mount
strong
immun
respons
succumb
viral
dissemin
fact
develop
abdlik
featur
mainli
second
infect
could
keep
hypothesi
strong
immun
respons
elicit
antigen
rechalleng
main
determin
vascul
interest
infecti
etiolog
vascul
recent
rekindl
worldwid
spread
hiv
hivand
opportunisticagentinduc
vascul
report
hivinfect
individu
dissect
mechan
underli
hivassoci
vasculopathi
tinkl
et
al
develop
model
transgen
mice
carri
replicationdefect
proviru
select
delet
gag
pol
env
gene
major
transgen
mice
develop
extens
vasculopathi
vessel
differ
size
vessel
histolog
reveal
intima
hyperplasia
like
due
migrat
smooth
muscl
cell
media
hypocellular
medial
layer
predominantli
adventiti
infiltr
consist
primarili
cell
occasion
plasma
cell
monocyt
endotheli
cell
appar
unaffect
intim
thicken
gener
signific
lumin
narrow
vessel
restrict
blood
flow
lead
ischemia
involv
tissu
express
hiv
nonstructur
gene
appear
confin
smooth
muscl
cell
keep
abnorm
prolifer
cell
type
interest
prolifer
smooth
muscl
cell
occur
anim
absenc
detect
inflammatori
cell
infiltr
suggest
smooth
muscl
cell
primari
target
hiv
wherea
adventiti
immunemedi
respons
probabl
repres
secondari
event
find
intrigu
howev
model
reliabl
reproduc
characterist
human
hivassoci
vasculopathi
fact
endotheli
cell
demonstr
often
affect
hivinfect
individu
wherea
broad
spectrum
hiv
vascul
seem
involv
multipl
mechan
mutual
interact
still
fulli
unravel
conclus
anim
model
vascul
prove
valuabl
promot
knowledg
etiolog
pathogenesi
vascul
potenti
import
therapeut
implic
variat
clinic
pattern
andor
sever
vascul
observ
infect
anim
could
provid
excel
opportun
investig
factor
contribut
determin
diseas
cours
time
caution
exert
extrapol
experiment
find
human
diseas
model
seem
reliabl
reproduc
featur
human
vascul
possibl
except
leukocytoclast
vascul
treponema
pallidum
known
caus
ascend
aortiti
aortiti
secondari
syphili
infect
low
preval
occur
tertiari
stage
diseas
serolog
pallidum
posit
histolog
aorta
show
destruct
fibrosi
media
dens
inflammatori
infiltr
consist
lymphocyt
plasma
cell
around
vasa
vasorum
adventitia
howev
pallidum
rare
detect
arteri
wall
lesion
syphilit
aortiti
confus
aortiti
secondari
gca
takayasu
arter
complic
syphili
retin
cerebr
vascul
tubercul
aortoarter
usual
caus
direct
extens
diseas
adjac
tubercul
tissu
occasion
bloodborn
seedl
activ
distant
focu
tubercul
aortiti
gener
develop
distal
aortic
arch
descend
aorta
close
mediastin
lymph
node
involv
ascend
aorta
also
report
except
rule
true
fals
aneurysm
common
manifest
drug
sometim
surgic
treatment
requir
retin
vascul
also
link
one
studi
mycobacterium
tuberculosi
infect
rickettsia
oblig
intracellular
bacteria
caus
widespread
vasculopathi
directli
affect
endothelium
lead
microvascular
leakag
thrombosi
laboratori
test
usual
reveal
thrombocytopenia
elev
prothrombin
partial
thromboplastin
time
hepatitisbassoci
polyarter
nodosa
hepat
b
viru
hbv
recogn
caus
agent
polyarter
nodosa
pan
like
via
format
immun
complex
howev
declin
hbv
infect
mainli
due
develop
specif
vaccin
aggress
vaccin
campaign
preval
hbv
infect
individu
pan
steadili
decreas
time
fact
recent
estim
franc
suggest
current
case
pan
hbv
relat
hbvpan
usual
becom
manifest
mean
month
follow
exposur
hbv
hepat
still
undiagnos
clinic
hbvpan
virtual
indistinguish
classic
pan
relaps
rare
combin
therapi
brief
cours
approxim
week
glucocorticoid
associ
antivir
agent
lamivudin
mgday
ifna
unit
subcutan
three
time
week
taper
scheme
advoc
basi
retrospect
data
show
poorer
outcom
follow
therapi
glucocorticoid
immunosuppress
hbvpan
compar
idiopath
pan
plasma
exchang
also
report
use
sever
case
hepat
cassoci
cryoglobulinem
vascul
hepat
c
viru
hcv
infect
shown
induc
type
ii
less
frequent
type
iii
cryoglobulin
howev
cryoglobulinem
vascul
usual
smallvessel
leukocytoclast
type
develop
patient
detect
cryoglobulin
common
clinic
manifest
includ
purpura
glomerulonephr
peripher
neuropathi
arthriti
sicca
syndrom
laboratori
test
usual
reveal
low
sometim
posit
rheumatoid
factor
variou
lowtit
autoantibodi
also
report
treatment
hcv
vascul
tailor
sever
diseas
patient
mild
diseas
without
sever
organ
involv
lifethreaten
diseas
antivir
therapi
ifna
unitsthre
time
week
without
lowdos
glucocorticoid
month
follow
mainten
therapi
ifna
without
ribavirin
month
suffic
howev
relaps
frequent
particularli
hcv
erad
patient
major
organ
involv
cours
induct
therapi
puls
cyclophosphamid
glucocorticoid
requir
follow
mainten
antivir
therapi
month
patient
lifethreaten
diseas
treat
aggress
oral
cyclophosphamid
glucocorticoid
puls
plasmapheresi
month
remiss
induct
antivir
therapi
commenc
patient
refractori
vascul
glomerulonephr
rituximab
could
valuabl
therapeut
option
advent
aid
epidem
variou
type
vasculopathi
increasingli
describ
hivinfect
patient
opportunist
infect
mainli
due
cmv
tuberculosi
report
mainli
immunodefici
patient
rout
transmiss
hiv
also
share
hbv
hcv
surpris
virus
implic
caus
agent
case
even
immunocompet
host
druginduc
vascul
also
infrequ
mani
case
howev
hiv
seem
directli
induc
vasculopathi
differ
type
retrospect
review
symptomat
hivinfect
patient
refer
muscl
nerv
skin
biopsi
document
presenc
vascul
patient
variou
vasculit
type
recogn
includ
necrot
arter
patient
nonnecrot
arter
patient
neutrophil
vascul
patient
mononuclear
vascul
patient
smallvessel
inflammatori
chang
patient
accord
american
colleg
rheumatolog
criteria
patient
could
classifi
distinct
categori
vascul
includ
pan
patient
nlein
purpura
patient
druginduc
hypersensit
vascul
patient
wherea
classifi
unspecifi
vascul
vasculitid
seen
differ
stage
hiv
infect
one
patient
hbv
surfac
antigenemia
two
cryoglobulinemia
two
coinfect
human
lymphotrop
viru
type
cmv
inclus
antigen
detect
endotheli
cell
one
patient
hiv
antigen
genom
detect
perivascular
cell
two
three
patient
necrot
arter
immun
deposit
found
smallvessel
wall
five
skin
biopsi
sampl
show
small
vessel
vascul
muscl
three
patient
necrot
arter
data
indic
wide
rang
inflammatori
vascular
diseas
occur
hivinfect
individu
high
frequenc
vascul
cohort
hiv
patient
probabl
overestim
relat
referr
bia
like
patient
symptom
sign
suggest
vascul
underw
biopsi
realist
estim
true
preval
vascul
hivinfect
individu
rang
less
polyarter
nodosa
report
occur
set
hiv
infect
absenc
hepat
b
surfac
antigen
hbsag
posit
pathogenesi
hivpan
probabl
mediat
immun
complex
studi
group
fail
detect
insitu
hybrid
provir
dna
skin
sampl
compar
classic
pan
hivassoci
variant
appear
less
often
chronic
frequent
limit
peripher
nerv
muscl
might
account
less
sever
cours
observ
hiv
patient
along
line
hivpan
report
respond
well
moder
approxim
mgkgday
dose
prednison
recent
chetti
et
al
describ
hiv
patient
largevessel
vascul
character
aneurysm
occlus
diseas
clinic
manifest
includ
ruptur
aneurysm
transient
ischem
attack
hypertens
ischemia
lower
extrem
mass
site
aneurysm
arteri
affect
includ
common
carotid
abdomin
aorta
common
iliac
femor
poplit
patient
obviou
infect
vascular
lesion
although
one
patient
posit
tpha
treponema
pallidum
hemagglutin
test
test
syphili
wherea
cultur
blood
thrombu
content
anoth
patient
posit
staphylococcu
aureu
histolog
show
leukocytoclast
vascul
vasa
vasora
periadventiti
vessel
prolifer
slitlik
vascular
channel
chronic
inflamm
fibrosi
associ
medial
fibrosi
loss
fragment
muscl
elast
tissu
intim
chang
consist
duplic
fragment
intern
elast
lamina
calcif
base
find
author
argu
infect
immunecomplex
origin
result
leukocytoclast
vascul
vasa
vasora
periadventiti
vessel
intrigu
find
report
studi
presenc
slitlik
vascular
channel
lesion
observ
hivneg
individu
appear
fact
coincid
hiv
epidem
whether
lesion
repres
earli
stage
kaposi
sarcoma
known
angiogen
factor
postul
play
role
although
precis
pathogenesi
remain
unclear
vasculopathi
report
hivposit
patient
includ
vascul
character
acral
ischem
chang
angiocentr
immunoprolif
disord
necrot
granulomat
vascul
primari
pulmonari
hypertens
retin
vessel
alter
cotton
wool
infarct
hemorrhag
cerebr
vascul
howev
cerebr
vascul
account
minor
cerebr
ischem
lesion
given
wide
spectrum
vascular
alter
associ
hiv
infect
like
differ
pathogen
mechan
might
involv
specif
immun
complex
map
leukocytoclast
vascul
immun
dysregul
angiocentr
immunoprolif
disord
direct
effect
hiv
vascular
compon
immun
system
activ
product
inflammatori
cytokin
might
also
implic
howev
introduct
highli
activ
antiretrovir
treatment
associ
increas
risk
develop
immunemedi
disord
via
activ
immun
system
appear
impact
frequenc
hivvascul
immunolog
serolog
doubt
valu
differenti
diagnosi
vascul
occur
hiv
individu
hiv
infect
shown
stimul
synthesi
whole
array
autoantibodi
includ
antinucl
anticardiolipin
antineutrophil
cytoplasm
antibodi
anca
particular
anca
posit
shown
correl
develop
ancaassoci
vascul
patient
hiv
high
index
suspicion
vascul
maintain
patient
hiv
mani
clinic
manifest
constitut
symptom
cutan
lesion
might
sign
vascul
could
also
due
hiv
infect
absenc
vascul
antivir
therapi
limit
data
treatment
hivvascul
glucocorticoid
consid
drug
choic
uncontrol
observ
suggest
role
immunosuppress
plasmapheresi
resist
case
circumstanti
evid
suggest
role
infecti
agent
pathogenesi
gca
includ
cyclic
fluctuat
incid
rate
time
activ
statu
antigenpres
dendrit
cell
adventiti
layer
tempor
arteri
howev
studi
search
infecti
trigger
produc
discord
result
particular
cp
find
giant
cell
arteri
report
studi
similarli
varicella
zoster
viru
implic
trigger
gca
one
studi
result
confirm
larger
studi
discord
find
also
report
parvoviru
variou
infect
describ
preced
onset
takayasu
arter
although
link
infect
vascul
never
conclus
proven
high
immunoglobulin
level
extract
tuberculosi
kda
heatshock
protein
demonstr
takayasu
patient
unaffect
control
suggest
tuberculosi
might
involv
pathogenesi
takayasu
arter
least
case
mediumand
smallvessel
vascul
nasal
carriag
aureu
map
increas
risk
flare
relaps
wegen
granulomatosi
prolong
trimethoprimsulfamethoxazol
therapi
report
reduc
relaps
risk
variou
infect
describ
associ
kawasaki
diseas
date
strongest
associ
report
new
coronaviru
casecontrol
studi
specimen
respiratori
secret
children
kawasaki
diseas
control
subject
children
without
kawasaki
diseas
match
age
time
specimen
obtain
test
posit
new
coronaviru
reversetranscriptas
polymeras
chain
reaction
number
pathogen
propos
etiolog
agent
cogan
syndrom
mainli
basi
serolog
find
far
associ
remain
specul
wide
array
infecti
agent
report
associ
vascul
cn
includ
pallidum
hcv
hiv
parvoviru
pneumonia
borrelia
burgdorferi
bacteria
fungi
also
implic
case
bacteri
viral
etiolog
postul
abd
adamantiad
abd
sign
report
one
two
week
verifi
contact
varieti
bacteria
particular
streptococc
strain
especi
streptococcu
sangui
hsv
postul
particip
etiolog
abd
specif
oral
bacteri
streptococc
antigen
hsv
dna
well
antistreptococc
antihsv
antibodi
detect
frequent
abd
patient
control
crossreact
microbi
human
hypothes
trigger
diseas
predispos
host
stimul
cell
induc
synthesi
proinflammatori
cytokin
convers
oral
administr
peptid
shown
amelior
abd
uveiti
human
multipl
infecti
noninfecti
agent
link
leukocytoclast
vascul
nlein
purpura
two
condit
share
number
featur
includ
skin
purpura
sometim
histori
preced
infect
case
immun
complex
probabl
pathogen
mechan
lead
vasculit
lesion
infecti
origin
leukocytoclast
vascul
estim
account
onethird
case
leukocytoclast
vascul
mani
infecti
agent
occasion
link
differ
type
vasculitisoften
unclassifi
human
report
associ
often
specul
might
explain
chanc
alon
epsteinbarr
viru
ebv
cmv
among
frequent
report
infect
trigger
vascul
specif
ebv
implic
pathogenesi
leukocytoclast
granulomat
vascul
well
vascul
character
widespread
largevessel
coronari
arteri
aneurysm
patient
duncan
diseas
condit
character
select
ebvspecif
immun
defect
ebv
map
lymphocyt
vascul
corioretin
lymphomatoid
granulomatosi
cmv
known
opportunist
agent
reactiv
immunocompromis
host
result
system
vascul
howev
isol
report
suggest
cmv
vascul
might
also
occur
immunocompet
subject
cmv
vascul
dissemin
involv
one
organ
skin
gastrointestin
tract
cn
frequent
affect
patholog
find
includ
intraendotheli
viral
inclus
inflammatori
infiltr
vessel
wall
lumin
chang
anoth
viru
found
caus
mainli
retin
vascul
addit
wellknown
complic
tcell
leukemia
list
pathogen
implic
classifi
unclassifi
human
vascul
shown
box
data
human
studi
anim
model
consist
indic
number
infecti
agent
trigger
vascul
suscept
host
differ
agent
induc
type
vascul
case
leukocytoclast
vascul
exemplifi
convers
agent
give
rise
varieti
host
respons
rang
clinic
silent
infect
local
organ
involv
devast
widespread
vascul
expos
subject
develop
clinic
detect
vascul
organ
involv
probabl
either
mount
switch
effici
immun
respons
congenit
resist
given
pathogen
instanc
individu
lack
chemokin
port
entri
requir
hiv
strain
resist
hiv
infect
even
repeat
exposur
viru
mani
infecti
agent
display
vari
degre
tropism
differ
organ
vascular
bed
tropism
might
due
express
offend
agent
surfac
molecul
bind
specif
host
ligand
differ
tissu
vascular
segment
howev
persist
microorgan
certain
site
might
also
result
inabl
immun
system
clear
pathogen
site
variabl
diseas
sever
recogn
featur
experiment
well
human
vascul
modul
diseas
sever
still
poorli
understood
antigen
load
probabl
antigen
properti
effici
immun
respons
might
play
role
ifng
shown
key
mediat
antigendriven
immun
respons
experiment
model
mediat
also
implic
anoth
relat
issu
vascul
run
selflimit
cours
case
becom
chronic
other
theoret
persist
vascul
could
due
host
inabl
erad
infect
switch
immun
respons
trigger
infect
agent
clear
report
resolut
virusrel
vascul
viru
erad
achiev
would
appear
support
first
hypothesi
howev
limit
data
mainli
anim
invitro
studi
suggest
microorgan
might
also
induc
vascul
via
hit
run
mechan
furthermor
viral
infect
immun
respons
shown
interact
prevent
infecti
agent
becom
reactiv
without
fulli
erad
provok
vascul
organ
damag
ifng
appear
crucial
involv
block
viral
reactiv
role
infecti
agent
pathogenesi
primari
vasculitid
still
debat
instanc
numer
agent
implic
pathogenesi
gca
find
specif
infect
consist
replic
differ
detect
method
hit
run
diseas
induct
follow
clearanc
offend
agent
differ
etiolog
agent
lead
develop
vascul
differ
individu
might
explain
least
partial
discrep
report
literatur
therapeut
implic
recognit
infect
etiolog
vascul
theoret
treatment
aim
erad
caus
pathogen
would
logic
choic
howev
sever
vascul
might
addit
requir
immunosuppress
therapi
attain
rapid
diseas
control
final
import
rememb
factor
patient
age
genet
makeup
anatom
characterist
vessel
involv
might
contribut
regul
diseas
express
challeng
thu
establish
etiolog
infectionrel
vascul
also
determin
diseas
express
modul
turn
better
knowledg
interplay
infect
agent
host
factor
could
result
effect
therapeut
approach
consid
infect
caus
patient
vascul
posit
autoantibodi
includ
antineutrophil
cytoplasm
antibodi
report
vascul
proven
infecti
origin
vascul
infecti
origin
might
requir
immunosuppress
therapi
addit
erad
treatment
avail
clinic
pictur
domin
sever
manifest
establish
role
cytokin
factor
might
account
differ
suscept
infect
agent
induc
vascul
investig
mechan
contribut
persist
sever
vascul
investig
mechan
underpin
tropism
infect
agent
specif
organ
